But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. So, the natural ...

Fintel reports that on January 6, 2026, Citigroup upgraded their outlook for Arvinas (NasdaqGS:ARVN) from Neutral to Buy. Analyst Price Forecast Suggests 11.58% Upside As of December 22, 2025, the ...

The U.S. had a Christmas gift for each of the men in South Viet Nam’s 1st Regiment of the 1st Division, based just south of the Demilitarized Zone. It was the lightweight, fast-firing M-16 rifle, ...

Arvinas (ARVN) remains in the red, with losses increasing at a rate of 7.7% per year over the past five years and revenue projected to grow just 1.1% annually, which is well below the US market ...

BTIG analyst Jeet Mukherjee reiterated a Buy rating on Arvinas Holding Company today and set a price target of $14.00. The company’s shares closed yesterday at $9.59. Take advantage of TipRanks ...

All right, everyone. I think we'll get started here with the afternoon session. My name is Derek Archila. I'm one of the Wells Fargo biotech analysts. Very excited to have the Arvinas team here. From ...

I favor biotech stocks trading below cash value after setbacks; Arvinas (ARVN) fits this description, dropping 25% on Thursday after ending two Phase 3 trials. ARVN's net cash per share is over $12, ...

BOSTON, MA / ACCESS Newswire / May 2, 2025 / Block & Leviton is investigating Arvinas, Inc. (Nasdaq:ARVN) for potential securities law violations. Investors who have lost money in their Arvinas, Inc.

Fintel reports that on May 2, 2025, Jefferies downgraded their outlook for Arvinas (NasdaqGS:ARVN) from Buy to Hold. Analyst Price Forecast Suggests 238.05% Upside As of April 24, 2025, the average ...

HC Wainwright restated their buy rating on shares of Arvinas (NASDAQ:ARVN – Free Report) in a research report report published on Monday morning,Benzinga reports. They currently have a $81.00 price ...